During the past decade, The Affiliated Hospital of Hangzhou Normal University conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 3 clinical trials were completed, i.e. on average, 13% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 3 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Affiliated Hospital of Hangzhou Normal University" #1 sponsor was "Boehringer Ingelheim" with 7 trials, followed by "Fatty Liver and Alcoholic Liver Disease Study Group, China" with 2 trials sponsored, "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 2 trials sponsored, "Beijing Shenogen Biomedical Co., Ltd" with 1 trials sponsored and "Chipscreen Biosciences, Ltd." with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Affiliated Hospital of Hangzhou Normal University" #1 collaborator was "The Affiliated Hospital of Hangzhou Normal University" with 5 trials as a collaborator, "Unimed Scientific Inc." with 2 trials as a collaborator, "Affiliated Cancer Hospital & Institute of Guangzhou Medical University" with 1 trials as a collaborator, "Affiliated Hangzhou First People's Hospital" with 1 trials as a collaborator and "Anhui Provincial Hospital" with 1 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "The Affiliated Hospital of Hangzhou Normal University" are "Stroke" (3 trials), "Coronary Artery Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Hepatitis B, Chronic" (2 trials) and "Hypertension, Portal" (2 trials). Many other conditions were trialed in "The Affiliated Hospital of Hangzhou Normal University" in a lesser frequency.

Most popular intervention types in "The Affiliated Hospital of Hangzhou Normal University" are "Drug" (19 trials), "Device" (2 trials), "Behavioral" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "BI 685509" (2 trials), "Empagliflozin" (2 trials), "2mg of ASC41" (1 trials) and "4mg of ASC41 (2 tablets of 2 mg ASC41)" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Affiliated Hospital of Hangzhou Normal University" are 26 trials for "All" genders.

Currently, there are NaN active trials in "The Affiliated Hospital of Hangzhou Normal University". 2 are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in The Affiliated Hospital of Hangzhou Normal University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Affiliated Hospital of Hangzhou Normal University, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".